Altogether, obtained findings open interesting perspectives to the applicability of ApoB-derived cryptides in the treatment of bacterial chronic infections associated with biofilm formation and characterized by MDR phenotype, such as those affecting CF patients, and to the development in the future of successful combinatorial therapeutic approaches based on the concomitant administration of peptides and conventional antibiotics. The gene discussed is APOB; the disease is cystic fibrosis.